|
DK2992098T3
(da)
|
2013-05-01 |
2019-06-17 |
Ionis Pharmaceuticals Inc |
Sammensætninger og fremgangsmåder til modulering af hbv- og ttr-ekspression
|
|
EA036496B1
(ru)
*
|
2014-05-01 |
2020-11-17 |
Ионис Фармасьютикалз, Инк. |
Конъюгированные олигонуклеотиды для модулирования экспрессии фактора комплемента b
|
|
WO2015179693A1
(en)
|
2014-05-22 |
2015-11-26 |
Isis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
|
EP3151839A4
(en)
*
|
2014-06-06 |
2018-02-28 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for enhanced intestinal absorption of conjugated oligomeric compounds
|
|
DK3569711T3
(da)
|
2014-12-15 |
2021-02-22 |
Dicerna Pharmaceuticals Inc |
Ligandmodificerede dobbeltstrengede nukleinsyrer
|
|
EP3303365A4
(en)
*
|
2015-05-29 |
2019-04-24 |
Ascendis Pharma Inc. |
PRODRUGS WITH A PYROGLUTAMATE LINKER
|
|
WO2017010575A1
(ja)
*
|
2015-07-16 |
2017-01-19 |
協和発酵キリン株式会社 |
β２ＧＰＩ遺伝子発現抑制核酸複合体
|
|
CN105524124B
(zh)
*
|
2015-12-31 |
2018-10-30 |
天津英吉诺科技有限公司 |
一种n-乙酰氨基半乳糖的绿色合成方法
|
|
AU2017213404A1
(en)
|
2016-01-29 |
2018-09-20 |
Kyowa Kirin Co., Ltd. |
Nucleic acid conjugate
|
|
CA3011946A1
(en)
|
2016-03-07 |
2017-09-14 |
Arrowhead Pharmaceuticals, Inc. |
Targeting ligands for therapeutic compounds
|
|
WO2017178656A1
(en)
|
2016-04-14 |
2017-10-19 |
Roche Innovation Center Copenhagen A/S |
TRITYL-MONO-GalNAc COMPOUNDS AND THEIR USE
|
|
US11390867B2
(en)
|
2016-04-29 |
2022-07-19 |
Nanyang Technological University |
G-quadruplex-containing antisense oligonucleotides
|
|
TWI746590B
(zh)
*
|
2016-06-30 |
2021-11-21 |
日商協和麒麟股份有限公司 |
核酸複合體
|
|
WO2018013525A1
(en)
|
2016-07-11 |
2018-01-18 |
Translate Bio Ma, Inc. |
Nucleic acid conjugates and uses thereof
|
|
US10781175B2
(en)
*
|
2016-07-15 |
2020-09-22 |
Am Chemicals Llc |
Solid supports and phosphoramidite building blocks for oligonucleotide conjugates
|
|
SG11201901841TA
(en)
|
2016-09-02 |
2019-03-28 |
Arrowhead Pharmaceuticals Inc |
Targeting ligands
|
|
US11400161B2
(en)
|
2016-10-06 |
2022-08-02 |
Ionis Pharmaceuticals, Inc. |
Method of conjugating oligomeric compounds
|
|
EP3594346A4
(en)
|
2017-03-10 |
2020-12-16 |
National Center For Child Health And Development |
ANTISENS OLIGONUCLEOTIDE AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF TYPE IA GLYCOGEN STORAGE DISEASE
|
|
KR20190123351A
(ko)
*
|
2017-03-22 |
2019-10-31 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
개질된 올리고뉴클레오티드 및 이의 치료 용도
|
|
DK3607069T3
(da)
|
2017-04-05 |
2022-11-21 |
Silence Therapeutics Gmbh |
Produkter og sammensætninger
|
|
KR102677783B1
(ko)
|
2017-04-28 |
2024-06-21 |
쿄와 기린 가부시키가이샤 |
올리고뉴클레오티드 유도체 또는 그 염
|
|
TW201920668A
(zh)
*
|
2017-08-02 |
2019-06-01 |
日商協和醱酵麒麟有限公司 |
核酸複合體
|
|
WO2019027015A1
(ja)
*
|
2017-08-02 |
2019-02-07 |
協和発酵キリン株式会社 |
核酸複合体
|
|
EA202090720A1
(ru)
*
|
2017-09-14 |
2020-07-07 |
Янссен Байофарма, Инк. |
ПРОИЗВОДНЫЕ GalNAc
|
|
WO2019105404A1
(zh)
*
|
2017-12-01 |
2019-06-06 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
CN110945131B
(zh)
*
|
2017-12-01 |
2024-05-28 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
EP3719126B1
(en)
|
2017-12-01 |
2025-01-01 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, composition and conjugate containing nucleic acid, preparation method therefor and use thereof
|
|
DK3719128T3
(da)
*
|
2017-12-01 |
2025-03-03 |
Suzhou Ribo Life Science Co Ltd |
Dobbelt-strenget oligonukleotid, sammensætning og konjugat bestaende dobbelt-strenget oligonukleotid, fremgangsmåde herfor og anvendelse heraf
|
|
CA3083970A1
(en)
*
|
2017-12-01 |
2019-06-06 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, composition and conjugate comprising the same, and preparation method and use thereof
|
|
EP3719127A4
(en)
|
2017-12-01 |
2021-10-20 |
Suzhou Ribo Life Science Co., Ltd. |
NUCLEIC ACID, COMPOSITION AND CONJUGATE WITH IT, MANUFACTURING METHOD AND USE
|
|
CN110944675B9
(zh)
*
|
2017-12-01 |
2024-08-09 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
AU2018394875B2
(en)
|
2017-12-29 |
2023-08-03 |
Suzhou Ribo Life Science Co., Ltd. |
Conjugates and preparation and use thereof
|
|
WO2019140102A1
(en)
|
2018-01-10 |
2019-07-18 |
Translate Bio Ma, Inc. |
Compositions and methods for facilitating delivery of synthetic nucleic acids to cells
|
|
KR102398295B1
(ko)
*
|
2018-03-09 |
2022-05-17 |
다이이찌 산쿄 가부시키가이샤 |
당원병 Ia형 치료약
|
|
EP3775209A1
(en)
*
|
2018-04-05 |
2021-02-17 |
Silence Therapeutics GmbH |
Sirnas with at least two ligands at different ends
|
|
MX2020011570A
(es)
|
2018-05-07 |
2020-11-24 |
Alnylam Pharmaceuticals Inc |
Administracion extrahepatica.
|
|
WO2020038377A1
(zh)
|
2018-08-21 |
2020-02-27 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的药物组合物和缀合物及其用途
|
|
US11896674B2
(en)
|
2018-09-30 |
2024-02-13 |
Suzhou Ribo Life Science Co., Ltd. |
SiRNA conjugate, preparation method therefor and use thereof
|
|
GB2579253A
(en)
*
|
2018-11-28 |
2020-06-17 |
Pedanius Therapeutics Ltd |
Antibacterial antisense agents
|
|
AU2019390097A1
(en)
|
2018-11-30 |
2021-07-15 |
Kyowa Kirin Co., Ltd. |
Nucleic acid conjugate
|
|
GB201821269D0
(en)
|
2018-12-28 |
2019-02-13 |
Nippon Shinyaku Co Ltd |
Myostatin signal inhibitor
|
|
WO2020135673A1
(zh)
|
2018-12-28 |
2020-07-02 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
CN111377985B
(zh)
*
|
2018-12-29 |
2023-11-10 |
苏州瑞博生物技术股份有限公司 |
化合物和缀合物及其制备方法和用途
|
|
CN111377984B
(zh)
*
|
2018-12-29 |
2024-03-05 |
苏州瑞博生物技术股份有限公司 |
化合物和缀合物及其制备方法和用途
|
|
CN113330117B
(zh)
*
|
2019-01-18 |
2024-05-28 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
US12590304B2
(en)
|
2019-05-22 |
2026-03-31 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
|
|
AU2020280439B2
(en)
*
|
2019-05-22 |
2025-08-14 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
|
|
KR20220011689A
(ko)
*
|
2019-05-22 |
2022-01-28 |
쑤저우 리보 라이프 사이언스 컴퍼니, 리미티드 |
핵산, 약제학적 조성물, 접합체, 제조 방법, 및 용도
|
|
JP7606758B2
(ja)
|
2019-05-22 |
2024-12-26 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
核酸、薬物組成物及び複合体ならびに調製方法と使用
|
|
CN111973619B
(zh)
*
|
2019-05-23 |
2024-01-30 |
苏州瑞博生物技术股份有限公司 |
核酸、含有该核酸的药物组合物与siRNA缀合物及制备方法和用途
|
|
CN111973618B
(zh)
*
|
2019-05-23 |
2024-02-02 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与siRNA缀合物及制备方法和用途
|
|
US20220315929A1
(en)
|
2019-05-24 |
2022-10-06 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition and conjugate, preparation method therefor and use thereof
|
|
CN113795280B
(zh)
*
|
2019-05-24 |
2024-04-05 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与缀合物及制备方法和用途
|
|
CN113795582B
(zh)
|
2019-05-24 |
2024-05-24 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与缀合物及制备方法和用途
|
|
CN112007040B
(zh)
*
|
2019-05-31 |
2024-01-30 |
苏州瑞博生物技术股份有限公司 |
用于治疗乙型病毒性肝炎的联合用药物
|
|
US20230076803A1
(en)
|
2019-08-29 |
2023-03-09 |
Suzhou Ribo Life Science Co., Ltd. |
Compound and drug conjugate, and preparation method and use thereof
|
|
IL291251B1
(en)
|
2019-09-10 |
2026-02-01 |
Daiichi Sankyo Co Ltd |
Oligonucleotide-galnac conjugate for targeted delivery to the liver and method for its production
|
|
CN115003330A
(zh)
|
2019-09-23 |
2022-09-02 |
科纳克斯资本 |
作为疫苗和诊断工具的新糖缀合物
|
|
BR112022007795A2
(pt)
*
|
2019-11-06 |
2022-07-05 |
Alnylam Pharmaceuticals Inc |
Administração extra-hepática
|
|
IL293341B1
(en)
*
|
2019-11-26 |
2026-04-01 |
Dtx Pharma Inc |
A compound comprising a nucleic acid and a half-life extension motif
|
|
CN112876534B
(zh)
*
|
2019-11-29 |
2024-02-09 |
苏州瑞博生物技术股份有限公司 |
肝靶向化合物及缀合物
|
|
EP4098655A4
(en)
*
|
2020-01-29 |
2024-02-28 |
Sumitomo Chemical Company, Limited |
METHOD FOR PRODUCING NUCLEIC ACID OLIGOMERS
|
|
CN111269279B
(zh)
*
|
2020-02-24 |
2022-08-05 |
陕西师范大学 |
一种在温和条件下制备卤代糖的方法
|
|
JP2023520763A
(ja)
|
2020-03-24 |
2023-05-19 |
ジェネレーション バイオ カンパニー |
ゴーシェ治療薬を発現するための非ウイルス性ｄｎａベクター及びその使用
|
|
US20230138409A1
(en)
|
2020-03-24 |
2023-05-04 |
Generation Bio Co. |
Non-viral dna vectors and uses thereof for expressing factor ix therapeutics
|
|
CN113683651A
(zh)
*
|
2020-05-19 |
2021-11-23 |
上海京新生物医药有限公司 |
一种GalNAc中间体的制备方法
|
|
MX2022014606A
(es)
|
2020-05-22 |
2023-03-08 |
Wave Life Sciences Ltd |
Composiciones de oligonucleótidos bicatenarios y métodos relacionados con las mismas.
|
|
TWI879977B
(zh)
|
2020-06-10 |
2025-04-11 |
大陸商正大天晴藥業集團股份有限公司 |
雙鏈siRNA類似物的共軛物
|
|
IL303886A
(en)
|
2020-12-23 |
2023-08-01 |
Flagship Pioneering Inc |
Compositions of modified trems and uses thereof
|
|
EP4273245A4
(en)
|
2020-12-29 |
2024-12-11 |
Suzhou Ribo Life Science Co., Ltd. |
NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND SIRNA CONJUGATE WITH THE NUCLEIC ACID, MANUFACTURING PROCESS THEREOF AND USE THEREOF
|
|
WO2022189861A1
(en)
|
2021-03-08 |
2022-09-15 |
Tollys |
Carbohydrate conjugates of tlr3 ligands and uses thereof
|
|
US20240216535A1
(en)
|
2021-04-27 |
2024-07-04 |
Generation Bio Co. |
Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof
|
|
AU2022264509A1
(en)
|
2021-04-27 |
2023-12-14 |
Generation Bio Co. |
Non-viral dna vectors expressing therapeutic antibodies and uses thereof
|
|
US20240335551A1
(en)
*
|
2021-05-20 |
2024-10-10 |
Olix Us, Inc. |
Functional moieties and their uses and synthetic preparation
|
|
CN115572241B
(zh)
*
|
2021-06-21 |
2024-08-30 |
润佳（苏州）医药科技有限公司 |
双价化合物、偶联物及其用途
|
|
CA3225573A1
(en)
|
2021-07-08 |
2023-01-12 |
Nippon Shinyaku Co., Ltd. |
Precipitation suppressing agent
|
|
CN118475355A
(zh)
|
2021-07-08 |
2024-08-09 |
日本新药株式会社 |
肾毒性减轻剂
|
|
TW202308664A
(zh)
|
2021-07-08 |
2023-03-01 |
日商日本新藥股份有限公司 |
腎毒性減輕劑
|
|
EP4372085A4
(en)
|
2021-07-16 |
2026-01-21 |
Suzhou Ribo Life Science Co Ltd |
Nucleic acid, composition and conjugate, container, preparation process and use
|
|
WO2023284763A1
(zh)
|
2021-07-16 |
2023-01-19 |
苏州瑞博生物技术股份有限公司 |
双链寡核苷酸、含双链寡核苷酸的组合物与缀合物及制备方法和用途
|
|
WO2023015223A2
(en)
*
|
2021-08-03 |
2023-02-09 |
Verve Therapeutics, Inc. |
Compositions and methods for targeted rna delivery
|
|
US12465647B2
(en)
|
2021-08-05 |
2025-11-11 |
Sanegene Bio Usa Inc. |
1′-alkyl modified ribose derivatives and methods of use
|
|
EP4405368A1
(en)
|
2021-09-22 |
2024-07-31 |
Sanegene Bio USA Inc. |
2'-alkyl or 3'- alkyl modified ribose derivatives for use in the in-vivo delivery of oligonucleotides
|
|
EP4413015A1
(en)
|
2021-10-05 |
2024-08-14 |
Sanegene Bio USA Inc. |
Polyhydroxylated cyclopentane derivatives and methods of use
|
|
WO2023097251A1
(en)
*
|
2021-11-23 |
2023-06-01 |
Yale University |
Oligonucleotide-containing transcription factor targeting chimeras
|
|
US20230346819A1
(en)
|
2022-02-22 |
2023-11-02 |
Sanegene Bio Usa Inc. |
5'-modified carbocyclic ribonucleotide derivatives and methods of use
|
|
WO2023171804A1
(ja)
|
2022-03-10 |
2023-09-14 |
日本新薬株式会社 |
抗ウイルスアンチセンスオリゴマー
|
|
CN119072330A
(zh)
|
2022-03-14 |
2024-12-03 |
世代生物公司 |
异源初免加强疫苗组合物和使用方法
|
|
EP4495240A1
(en)
|
2022-03-16 |
2025-01-22 |
Daiichi Sankyo Company, Limited |
Sirna for suppressing expression of transferrin receptor-2
|
|
US20250188477A1
(en)
|
2022-03-16 |
2025-06-12 |
Daiichi Sankyo Company, Limited |
CHEMICALLY MODIFIED OLIGONUCLEOTIDE HAVING RNAi ACTIVITY
|
|
WO2023207615A1
(zh)
*
|
2022-04-26 |
2023-11-02 |
南京明德新药研发有限公司 |
一类含由天然核苷酸组成突出端的双链RNAi化合物
|
|
WO2023212134A2
(en)
*
|
2022-04-28 |
2023-11-02 |
Dicerna Pharmaceuticals, Inc. |
Methods for synthesis of peracetylgalactosamine-1-pentanoic acid
|
|
EP4522742A2
(en)
|
2022-05-13 |
2025-03-19 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded loop oligonucleotides
|
|
US20250179492A1
(en)
|
2022-06-22 |
2025-06-05 |
Flagship Pioneering Innovations Vi, Llc |
Compositions of modified trems and uses thereof
|
|
CN119654412A
(zh)
*
|
2022-06-27 |
2025-03-18 |
中美瑞康核酸技术(南通)研究院有限公司 |
激活补体因子h表达的寡核苷酸调节剂
|
|
JP2025522880A
(ja)
|
2022-06-30 |
2025-07-17 |
アルナイラム ファーマシューティカルズ， インコーポレイテッド |
環状ジスルフィド修飾リン酸ベースのオリゴヌクレオチドプロドラッグ
|
|
EP4555088A1
(en)
|
2022-07-11 |
2025-05-21 |
Sanegene Bio USA Inc. |
Optimized 2'- modified ribose derivatives and methods of use
|
|
KR20250046303A
(ko)
|
2022-08-05 |
2025-04-02 |
사네진 바이오 유에스에이 인크. |
안지오텐시노겐 (agt)을 표적화하는 이중 가닥 rna 및 그의 사용 방법
|
|
US20260055426A1
(en)
|
2022-08-19 |
2026-02-26 |
Generation Bio Co. |
CLEAVABLE CLOSED-ENDED DNA (ceDNA) AND METHODS OF USE THEREOF
|
|
KR20250088573A
(ko)
|
2022-10-14 |
2025-06-17 |
사네진 바이오 유에스에이 인크. |
C3을 표적화하는 소형 간섭 rna 및 그의 용도
|
|
CR20250257A
(es)
|
2022-12-02 |
2025-08-28 |
Shanghai Argo Biopharmaceutical Co Ltd |
Análogos de ácidos nucleicos bicíclicos abásicos y compuestos oligoméricos preparados a partir de estos
|
|
WO2024137590A2
(en)
|
2022-12-19 |
2024-06-27 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting cfb and uses thereof
|
|
CN116178458A
(zh)
*
|
2022-12-26 |
2023-05-30 |
成都药明康德新药开发有限公司 |
一种糖苷化合物的合成
|
|
WO2024160204A1
(en)
*
|
2023-01-30 |
2024-08-08 |
Primelink Biotherapeutics (Suzhou) Co., Ltd. |
Polymer-oligonucleotide conjugates
|
|
US20240309383A1
(en)
|
2023-02-24 |
2024-09-19 |
Suzhou Sanegene Bio Inc. |
Small interfering rna targeting hbv and uses thereof
|
|
WO2024186673A2
(en)
|
2023-03-03 |
2024-09-12 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting apoc3 and uses thereof
|
|
WO2024188174A1
(zh)
|
2023-03-10 |
2024-09-19 |
苏州瑞博生物技术股份有限公司 |
一种药物组合物及其用途
|
|
EP4709855A2
(en)
|
2023-05-12 |
2026-03-18 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded loop oligonucleotides
|
|
AU2024280172A1
(en)
|
2023-06-01 |
2025-12-04 |
Sunshine Lake Pharma Co., Ltd. |
Novel double-stranded sirna, conjugate thereof, and use thereof
|
|
WO2024263915A2
(en)
|
2023-06-21 |
2024-12-26 |
Sanegene Bio Usa Inc. |
Double stranded rna targeting proprotein convertase subtilisin kexin 9 (pcsk9) and methods of use thereof
|
|
CN119219716A
(zh)
*
|
2023-06-30 |
2024-12-31 |
上海维申医药有限公司 |
新型GalNAc的靶向递送片段及其制备和应用
|
|
WO2025016441A1
(zh)
*
|
2023-07-19 |
2025-01-23 |
上海维申医药有限公司 |
新型GalNAc的靶向递送片段及其制备和应用
|
|
US20250064939A1
(en)
|
2023-07-24 |
2025-02-27 |
Sanegene Bio Usa Inc. |
Lipid-based enhancement agent for rna delivery and therapy
|
|
AU2024321710A1
(en)
|
2023-08-04 |
2026-03-05 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Double-stranded ribonucleic acid targeting pd-l1
|
|
CN119464281A
(zh)
|
2023-08-09 |
2025-02-18 |
北京福元医药股份有限公司 |
抑制DGAT2基因表达的siRNA、siRNA缀合物或其前药和药物组合物及用途
|
|
WO2025042786A1
(en)
|
2023-08-18 |
2025-02-27 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising circular polyribonucleotides and uses thereof
|
|
CN121729496A
(zh)
|
2023-08-31 |
2026-03-24 |
正大天晴药业集团股份有限公司 |
靶向凝血因子xi的双链核糖核酸
|
|
CN117384226B
(zh)
*
|
2023-09-14 |
2025-12-26 |
苏州盛诺维生物科技有限公司 |
一种GalNAc类化合物的合成工艺
|
|
WO2025096809A1
(en)
|
2023-10-31 |
2025-05-08 |
Korro Bio, Inc. |
Oligonucleotides comprising phosphoramidate internucleotide linkages
|
|
US20250161347A1
(en)
|
2023-11-22 |
2025-05-22 |
Flagship Pioneering Innovations Vii, Llc |
Methods and compositions for treating non-alcoholic fatty liver disease
|
|
CN120209036A
(zh)
*
|
2023-12-26 |
2025-06-27 |
广东东阳光药业股份有限公司 |
一种新型的化合物及其用途
|
|
WO2025155911A1
(en)
|
2024-01-18 |
2025-07-24 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for the treatment of hurler syndrome
|
|
TW202602932A
(zh)
|
2024-03-28 |
2026-01-16 |
美商萊西亞醫療公司 |
用於降解甲狀腺刺激荷爾蒙受體自體抗體之胞溶體靶向雙功能分子
|
|
WO2025228441A2
(en)
|
2024-04-30 |
2025-11-06 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting inhbe and uses thereof
|
|
CN118146284B
(zh)
*
|
2024-05-08 |
2024-07-26 |
北京悦康科创医药科技股份有限公司 |
一种GalNAc化合物、其与寡核苷酸缀合物及制备方法
|
|
WO2025245188A2
(en)
|
2024-05-21 |
2025-11-27 |
Flagship Pioneering Innovations Vii, Llc |
Methods of treating liver steatosis and non-alcoholic fatty liver disease
|
|
WO2026017140A2
(en)
|
2024-07-18 |
2026-01-22 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting fxi and uses thereof
|
|
WO2026041067A2
(en)
|
2024-08-20 |
2026-02-26 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting myostatin (mstn) and uses thereof
|
|
WO2026046411A1
(en)
|
2024-09-02 |
2026-03-05 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting plasminogen (plg) and uses thereof
|
|
WO2026085495A1
(en)
|
2024-10-18 |
2026-04-23 |
Generation Bio Co. |
Synthetic partially single-stranded nucleic acid compositions and uses and methods therefor
|
|
CN121081660A
(zh)
*
|
2025-02-21 |
2025-12-09 |
上海辉棵生物医药有限公司 |
一种靶向递送系统及其核酸缀合物的制备方法与用途
|